This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Peptides & Oligonucleotides

The Potential of mRNA Therapeutics

Posted by on 21 June 2023
Share this article

Pad Chivukula, Chief Scientific Officer and Chief Operating Officer at Arcturus Therapeutics, discusses the potential of messenger RNA (mRNA) therapeutics in an interview at the TIDES USA conference in San Diego, Calif. Chivukula also highlights the versatility of mRNA technology and its transformative impact on healthcare beyond vaccines. Arcturus is actively developing RNA-based drugs for a range of medical applications, including treatment of rare diseases such as cystic fibrosis.

Share this article